Brain Tumor Centers

Find U.S. facilities with actively recruiting interventional brain-tumor trials. Choose one state at a time; facility details load only after you select a facility.

Back to facilities in Washington

Providence Sacred Heart Medical Center and Children's Hospital

Spokane, Washington 99204

Reported site contacts

Judy L. Felgenhauer — principal investigator
Trial: NCT04166409

Judy L. Felgenhauer — principal investigator
Trial: NCT04684368

Judy L. Felgenhauer — principal investigator
Trial: NCT05099003

Judy L. Felgenhauer — principal investigator
Trial: NCT05382338

Site Public Contact — contact
hopebeginshere@providence.org
800-228-6618
Trial: NCT04166409

Site Public Contact — contact
hopebeginshere@providence.org
800-228-6618
Trial: NCT04684368

Site Public Contact — contact
hopebeginshere@providence.org
800-228-6618
Trial: NCT05099003

Site Public Contact — contact
hopebeginshere@providence.org
800-228-6618
Trial: NCT05382338

Recruiting trials at this facility

• A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT (NCT04684368)
  Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma, Malignant Teratoma, Mixed Germ Cell Tumor, Pineal Region Germ Cell Tumor, Pineal Region Immature Teratoma, Pineal Region Yolk Sac Tumor, Suprasellar Germ Cell Tumor
• A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) (NCT05099003)
  Malignant Glioma
• A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (NCT04166409)
  Low Grade Astrocytoma, Low Grade Glioma, Metastatic Low Grade Astrocytoma, Metastatic Low Grade Glioma, WHO Grade 1 Glioma, WHO Grade 2 Glioma
• A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss (NCT05382338)
  Childhood Medulloblastoma